Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

16.91
+0.52003.17%
Post-market: 16.90-0.0100-0.06%17:47 EDT
Volume:13.05M
Turnover:223.98M
Market Cap:13.49B
PE:-15.13
High:17.72
Open:16.59
Low:16.17
Close:16.39
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:1.41
T/O Rate:8.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.41
PE(LYR):-11.71

Loading ...

Movement Alert|Summit Therapeutics PLC Rises 5.03% in Regular Trading, AstraZeneca $2 Billion Investment Continues to Boost Sentiment

Market Focus
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday

AstraZeneca Hedges Threat to Oncology Portfolio

Dow Jones
·
Yesterday

UK Car Production Rises 5.7% in August

Deep News
·
Yesterday

FTSE 100 Hits Two-Week Low as Energy Stocks Slide

Reuters
·
Yesterday

Unusually active option classes on open September 29th

TIPRANKS
·
Sep 29

Movement Alert|Summit Therapeutics PLC Rises 18.98% in Regular Trading, AstraZeneca Invests $2 Billion to Deepen Ivonescimab Collaboration

Market Focus
·
Sep 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Leerink Partners Sticks to Its Hold Rating for Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 29

Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon

Deep News
·
Sep 29

US Stocks-US Stock Futures Tick Higher as Tech Steadies Though Oil, Yields Stay High

Reuters
·
Sep 29

Top Premarket Gainers

MT Newswires Live
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

AstraZeneca Strikes Clinical Collaboration with Summit to Test ADC Sonesitatug Vedotin with Ivonescimab in GI Cancers

Reuters
·
Sep 29

AMD, Nvidia, Navitas, Summit Therapeutics, Fair Isaac, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 29

FTSE 100 Rises as AstraZeneca Lifts Healthcare Sector

Reuters
·
Sep 29

AstraZeneca Dips Toes in Emerging Class of Cancer Drugs

Dow Jones
·
Sep 29

SMMT Rises 24% in Pre-Market Trading, AstraZeneca Invests $2 Billion to Deepen Ivonescimab Collaboration

Market Focus
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

AstraZeneca Shares up 2% to Two-Month High After Summit Therapeutics Investment

THOMSON REUTERS
·
Sep 29